Medical Design Briefs - January 2023 - 20
Inside the OEM
major platforms " that the company has
today. " We were lucky to be maintaining
let alone gaining share in half of
them. Today, 10 out of that 11 are either
maintained or improving share
position - so great job on the execution
side. Then with respect to the
pipeline portfolio in medtech - back
in that 2017-2018 timeframe, we had
six assets that were expected to deliver
about $100 million in net present value
each. Today there are more than 25 assets
in that pipeline. "
He also notes that J&J plans to play in
some higher-growth segments. " The
nice thing about the financial strength
in Johnson & Johnson is that we have
the ability to pursue meaningful acquisiThe
future of Abiomed's Impella
become even smaller and easier
technology is to
to imto
use,
prove patient outcomes with real-time intelligence
to optimize Impella therapy, and to keep
clinicians informed with cloud-based technology
to guide decision-making. (Credit: Abiomed)
tions in both pharma and medtech, so
we don't really have a bias, per se. We're
looking for the right opportunity where
we have a skill, a capability, and expertise
that will enhance the value of that
asset currently and will reward shareholders
for the risk that we're bearing
on their behalf. "
A More Competitive J&J
Following the spinoff of the consumer
business, Duato sees a stronger J&J
emerging. " I want to reinforce that we
are making sure that we use this opportunity
to create a Johnson & Johnson that is
more competitive, that is leaner from a
cost perspective, that is one that is more
aligned from pharma and medtech, and
that we continue to deliver optimal results
both in pharma and medtech. "
He also says J&J will create synergies between
the two sectors designed to enable
the company to run more efficiently and
that will ensure that J&J has more scale in
certain capabilities. These synergies could
translate into creating new products that
combine biopharmaceutical and surgical
interventions, similar to what the company
is doing in interventional oncology.
" While we are very keen on launching
our new consumer health company, we are
also taking this opportunity to accelerate
the growth of the new Johnson & Johnson, "
said Duato.
This article was written by Sherrie
Trigg, Editor and Director of Medical
Content. She can be reached at sherrie.
trigg@saemediagroup.com.
20
MDB maxon Digital Ad 0922.indd 1
www.medicaldesignbriefs.com
8/4/22 1:11 PM
Medical Design Briefs, January 2023
http://info.hotims.com/84475-766
http://info.hotims.com/84475-752
http://www.medicaldesignbriefs.com
Medical Design Briefs - January 2023
Table of Contents for the Digital Edition of Medical Design Briefs - January 2023
Medical Design Briefs - January 2023 - CV1A
Medical Design Briefs - January 2023 - CV1B
Medical Design Briefs - January 2023 - Cov1
Medical Design Briefs - January 2023 - Cov2
Medical Design Briefs - January 2023 - 1
Medical Design Briefs - January 2023 - 2
Medical Design Briefs - January 2023 - 3
Medical Design Briefs - January 2023 - 4
Medical Design Briefs - January 2023 - 5
Medical Design Briefs - January 2023 - 6
Medical Design Briefs - January 2023 - 7
Medical Design Briefs - January 2023 - 8
Medical Design Briefs - January 2023 - 9
Medical Design Briefs - January 2023 - 10
Medical Design Briefs - January 2023 - 11
Medical Design Briefs - January 2023 - 12
Medical Design Briefs - January 2023 - 13
Medical Design Briefs - January 2023 - 14
Medical Design Briefs - January 2023 - 15
Medical Design Briefs - January 2023 - 16
Medical Design Briefs - January 2023 - 17
Medical Design Briefs - January 2023 - 18
Medical Design Briefs - January 2023 - 19
Medical Design Briefs - January 2023 - 20
Medical Design Briefs - January 2023 - 21
Medical Design Briefs - January 2023 - 22
Medical Design Briefs - January 2023 - 23
Medical Design Briefs - January 2023 - 24
Medical Design Briefs - January 2023 - 25
Medical Design Briefs - January 2023 - 26
Medical Design Briefs - January 2023 - 27
Medical Design Briefs - January 2023 - 28
Medical Design Briefs - January 2023 - 29
Medical Design Briefs - January 2023 - 30
Medical Design Briefs - January 2023 - 31
Medical Design Briefs - January 2023 - 32
Medical Design Briefs - January 2023 - 33
Medical Design Briefs - January 2023 - 34
Medical Design Briefs - January 2023 - 35
Medical Design Briefs - January 2023 - 36
Medical Design Briefs - January 2023 - 37
Medical Design Briefs - January 2023 - 38
Medical Design Briefs - January 2023 - 39
Medical Design Briefs - January 2023 - 40
Medical Design Briefs - January 2023 - Cov3
Medical Design Briefs - January 2023 - Cov4
https://www.nxtbook.com/smg/techbriefs/24MDB09
https://www.nxtbook.com/smg/techbriefs/24MDB08
https://www.nxtbook.com/smg/techbriefs/24MDB07
https://www.nxtbook.com/smg/techbriefs/24MDB06
https://www.nxtbook.com/smg/techbriefs/24MDB05
https://www.nxtbook.com/smg/techbriefs/24MDB04
https://www.nxtbook.com/smg/techbriefs/24MDB03
https://www.nxtbook.com/smg/techbriefs/24MDB02
https://www.nxtbook.com/smg/techbriefs/24MDB01
https://www.nxtbook.com/smg/techbriefs/23MDB12
https://www.nxtbook.com/smg/techbriefs/23MDB11
https://www.nxtbook.com/smg/techbriefs/23MDB10
https://www.nxtbook.com/smg/techbriefs/23MDB09
https://www.nxtbook.com/smg/techbriefs/23MDB08
https://www.nxtbook.com/smg/techbriefs/23MDB07
https://www.nxtbook.com/smg/techbriefs/23MDB06
https://www.nxtbook.com/smg/techbriefs/23MDB05
https://www.nxtbook.com/smg/techbriefs/23MDB04
https://www.nxtbook.com/smg/techbriefs/23MDB03
https://www.nxtbook.com/smg/techbriefs/23MDB02
https://www.nxtbook.com/smg/techbriefs/23MDB01
https://www.nxtbook.com/smg/techbriefs/techleaders22
https://www.nxtbook.com/smg/techbriefs/22MDB12
https://www.nxtbook.com/smg/techbriefs/22MDB11
https://www.nxtbook.com/smg/techbriefs/22MDB10
https://www.nxtbook.com/smg/techbriefs/22MDB09
https://www.nxtbook.com/smg/techbriefs/22MDB08
https://www.nxtbook.com/smg/techbriefs/22MDB07
https://www.nxtbook.com/smg/techbriefs/22MDB06
https://www.nxtbook.com/smg/techbriefs/22MDB04
https://www.nxtbook.com/smg/techbriefs/techleaders21
https://www.nxtbook.com/smg/techbriefs/22MDB03
https://www.nxtbook.com/smg/techbriefs/22MDB02
https://www.nxtbook.com/smg/techbriefs/22MDB01
https://www.nxtbook.com/smg/techbriefs/21MDB12
https://www.nxtbook.com/smg/techbriefs/21MDB11
https://www.nxtbook.com/smg/techbriefs/21MDB10
https://www.nxtbook.com/smg/techbriefs/21MDB09
https://www.nxtbook.com/smg/techbriefs/21MDB08
https://www.nxtbook.com/smg/techbriefs/21MDB07
https://www.nxtbook.com/smg/techbriefs/21MDB06
https://www.nxtbook.com/smg/techbriefs/21MDB05
https://www.nxtbook.com/smg/techbriefs/21MDB04
https://www.nxtbook.com/smg/techbriefs/21MDB02
https://www.nxtbookmedia.com